Navigation Links
Sanofi US and POZEN Sign Exclusive License Agreement for the Commercialization of PA8140/PA32540 Tablets in the U.S.
Date:9/4/2013

cal application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the absence of guarantee that the product candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives, the Group's ability to benefit from external growth opportunities, trends in exchange rates and prevailing interest rates, the impact of cost containment policies and subsequent changes thereto, the average number of shares outstanding as well as those discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in Sanofi's annual report on Form 20-F for the year ended December 31, 2012. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.

POZEN Forward-Looking Statements Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on current market data and research (including third party and POZEN sponsored market studies and reports), management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our inability to license our PA product candidates on terms and timing acceptable to us, our inability to file a new drug application with the FDA for our PA product candidates in the timeframe we anticipate, our failure to successfully commercialize our product candidates; costs and delays in the devel
'/>"/>

SOURCE Sanofi US
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi Pasteurs Fluzone High-Dose Vaccine Significantly More Effective Than Standard Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older
2. Sanofi Pasteur Announces Shipment of First Lots of 2013-2014 Seasonal Influenza Vaccine in U.S.
3. Sanofi US and Joslin Diabetes Center Announce Results from Multicultural Outreach Pilot at American Diabetes Association Scientific Sessions
4. Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
5. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
6. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
7. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
8. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
9. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
10. Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)
11. NextBio Announces Translational Medicine Partnership with Sanofi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014 CVS Caremark Corporation (NYSE: CVS ... and consideration payable in connection with its previously announced cash ... for (1) any and all of its 6.250% Senior Notes ... to a maximum amount of its 6.125% Senior Notes due ... due 2017 (collectively, the "Maximum Tender Offer Notes" and together ...
(Date:8/21/2014)... Mass. , Aug. 21, 2014   ... AEX: PHIA) today announced it has received 510(k) ... to market its precision planning application for Transcatheter ... Philips TAVI application provides interventionalists with pre-procedural, high-precision ... The Philips TAVI planning application is available as ...
(Date:8/21/2014)... CHESTERBROOK, Pa. , Aug. 21, 2014 /PRNewswire/ ... AUXL ), a specialty biopharmaceutical company, today announced ... study of collagenase clostridium histolyticum (or CCH) for ... known as cellulite. In the Phase 2a trial, ... (0.48mg) and high (0.84mg)) showed an improvement in ...
Breaking Medicine Technology:CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7
... Wash., Nov. 9 Cardiac Science Corporation ... external defibrillator ( AED ) and diagnostic cardiac ... third quarter ended September 30, 2009, in line with its ... million for an AED field product update and a non-cash ...
... Nov. 9 Hill-Rom (NYSE: HRC ) ... venture that will focus on the sale and distribution of ... to be sold separate from a bed frame and as ... end of their useful life. Hill-Rom, a global leader ...
Cached Medicine Technology:Cardiac Science Announces Third Quarter Results 2Cardiac Science Announces Third Quarter Results 3Cardiac Science Announces Third Quarter Results 4Cardiac Science Announces Third Quarter Results 5Cardiac Science Announces Third Quarter Results 6Cardiac Science Announces Third Quarter Results 7Cardiac Science Announces Third Quarter Results 8Cardiac Science Announces Third Quarter Results 9Cardiac Science Announces Third Quarter Results 10Cardiac Science Announces Third Quarter Results 11Cardiac Science Announces Third Quarter Results 12Cardiac Science Announces Third Quarter Results 13Cardiac Science Announces Third Quarter Results 14Cardiac Science Announces Third Quarter Results 15Cardiac Science Announces Third Quarter Results 16Cardiac Science Announces Third Quarter Results 17Cardiac Science Announces Third Quarter Results 18Cardiac Science Announces Third Quarter Results 19Cardiac Science Announces Third Quarter Results 20Hill-Rom and Encompass Group Form Joint Venture 2Hill-Rom and Encompass Group Form Joint Venture 3Hill-Rom and Encompass Group Form Joint Venture 4Hill-Rom and Encompass Group Form Joint Venture 5
(Date:8/21/2014)... August 21, 2014 The costs paid by ... to rise, according to insurer data. The Quotes Pros company ... real time using its tools at http://quotespros.com . ... company homepage connects with providers offering multiple coverage packages for ... promoted to the public are now easier to compare using ...
(Date:8/21/2014)... BambooIndustry.com is an internationally well-known supplier and leader in ... new collection of elegant bamboo floorings . These ... looking for high quality floorings for their own houses. ... (up to 29 percent off). Before the end of ... , The company’s bamboo flooring products are made using ...
(Date:8/21/2014)... 2014 Recently, Van Uden Center ... Alternative medicine is on the rise and much ... to The Fiscal Times, young people are becoming ... medicine. , The Fiscal Times published an article ... embracing alternative medicine. The article can be found ...
(Date:8/21/2014)... Line: Patients with advanced laryngeal cancer appear to ... surgery than nonsurgical chemoradiation. , Author: Uchechukwu C. ... Medicine at Mount Sinai, New York, and colleagues. ... laryngeal cancer are diagnosed each year and squamous ... these tumors. Prior to 1991, total surgical removal ...
(Date:8/21/2014)... source of fungal infections that have been sickening HIV/AIDS ... on trees. , The discovery is based on the ... summer gathering soil and tree samples from areas around ... named Cryptococcus gattii (CRIP-to-cock-us GAT-ee-eye). ... species including C. gattii , causes life-threatening infections ...
Breaking Medicine News(10 mins):Health News:Dental Insurance Now Quoted for Families Online at Insurer Portal 2Health News:Buy Elegant Bamboo Floorings from Internationally Well-known Supplier BambooIndustry.com 2Health News:Van Uden Center Sees Growth in Alternative Medicine 2Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2Health News:Fungus deadly to AIDS patients found to grow on trees 2
... major changes in their lives and cooperate with public health ... according to the latest national survey // conducted by the ... and Biological Security. ,However, the survey also finds that ... care for them if they become ill or would face ...
... possession of child pornography material a federal crime is forcing ... or become one based on the child pornography being present ... are going to court and attorneys are calling us, wanting ... porn on their computer," said Dr. Humberto Temporini, a forensic ...
... after two minors died minutes after receiving an injection ... Chhattisgarh. ,Two brothers, Umashanker, 6 years, and Gaurishankar, ... injections for treatment of fever, cough and cold Friday ... of the same family, who were also given injections ...
... Eating Disorders, an international organization for eating disorder treatment, ... on the use of severely underweight models in fashion ... to adopt a minimum acceptable height-to-weight ratio in keeping ... ,“The unprecedented move of a major fashion ...
... confirmed that women who thrive on a diet which is rich ... like //which is highly refined energy food gain more weight and ... a diet rich in fiber and complex carbohydrates. ,Highly refined ... circulating sugar in the body in a sudden surge which is ...
... yesterday looks into support props for care givers of mentally ... relatives // and caregivers of mentally sick people in Ireland.Very ... sick goes beyond the realms of hospital in –patient care. ... by other care givers, often family members of the mentally ...
Cached Medicine News:Health News:Fears of Pandemic Flu makes Americans Ready for Change 2Health News:Fears of Pandemic Flu makes Americans Ready for Change 3Health News:Fears of Pandemic Flu makes Americans Ready for Change 4Health News:Fears of Pandemic Flu makes Americans Ready for Change 5Health News:Fears of Pandemic Flu makes Americans Ready for Change 6Health News:Does Child pornography lead to Child abuse? 2Health News:Does Child pornography lead to Child abuse? 3Health News:Academy for Eating Disorders Calls for Ban on Underweight Models 2
Triangle shape (3.0mm long) Tip with Sliding Inner Shaft, Squeeze Activates Shaft to Punch; overall length 130mm, in stainless steel...
Very fine, blunt tip....
... e.cam single-detector system offers general ... access for gurneys and wheelchairs. ... clinically versatile open gantry, caudal/cephalic ... contouring for SPECT and whole ...
Sharp diamond shaped double blade in stainless steel....
Medicine Products: